Q32 Bio Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Q32 Bio stock has a target of 13, which predicts an increase of 127.27% from the current stock price of 5.72.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$13	$13	$13	$13
Change	+127.27%	+127.27%	+127.27%	+127.27%

* Price targets were last updated on Feb 25, 2026.

Analyst Ratings

According to 1 stock analyst, the rating for Q32 Bio is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	0	0	0	1	1	1
Buy	3	3	3	0	0	0
Hold	5	5	5	1	1	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	8	2	2	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $13	Strong Buy	Initiates	$13	+127.27%	Feb 25, 2026
Derek Archila Wells Fargo	Wells Fargo	Hold Maintains $16 → $15	Hold	Maintains	$16 → $15	+162.24%	Mar 12, 2025
Etzer Darout BMO Capital	BMO Capital	Buy → Hold Downgrades $22 → $3	Buy → Hold	Downgrades	$22 → $3	-47.55%	Feb 11, 2025
Christopher Raymond Piper Sandler	Piper Sandler	Buy → Hold Downgrades $20 → $4	Buy → Hold	Downgrades	$20 → $4	-30.07%	Feb 11, 2025
Etzer Darout BMO Capital	BMO Capital	Buy Maintains $64 → $22	Buy	Maintains	$64 → $22	+284.62%	Dec 12, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 53.74M

Revenue Next Year

n/a

EPS This Year

-1.70

from 2.42

EPS Next Year

-3.63

from -1.70

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	6.65M	-6.65M	-	53.74M	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-5.81	-6.09	-153.96	-6.58	2.42	-1.70	-3.63
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-1.19	-2.16
Avg	-1.70	-3.63
Low	-2.17	-4.95

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.